Kidswell Bio Statistics
Total Valuation
Kidswell Bio has a market cap or net worth of JPY 7.14 billion. The enterprise value is 5.97 billion.
Important Dates
The last earnings date was Thursday, November 12, 2026.
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Kidswell Bio has 50.60 million shares outstanding. The number of shares has increased by 9.86% in one year.
| Current Share Class | 50.60M |
| Shares Outstanding | 50.60M |
| Shares Change (YoY) | +9.86% |
| Shares Change (QoQ) | +0.68% |
| Owned by Insiders (%) | 4.40% |
| Owned by Institutions (%) | -0.15% |
| Float | 36.20M |
Valuation Ratios
The trailing PE ratio is 58.87 and the forward PE ratio is 5.81.
| PE Ratio | 58.87 |
| Forward PE | 5.81 |
| PS Ratio | 1.24 |
| PB Ratio | 3.15 |
| P/TBV Ratio | 3.15 |
| P/FCF Ratio | 23.03 |
| P/OCF Ratio | 21.84 |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | 50.16 |
| EV / Sales | 1.04 |
| EV / EBITDA | n/a |
| EV / EBIT | 45.60 |
| EV / FCF | 19.29 |
Financial Position
The company has a current ratio of 2.76, with a Debt / Equity ratio of 1.00.
| Current Ratio | 2.76 |
| Quick Ratio | 1.89 |
| Debt / Equity | 1.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | 7.29 |
| Interest Coverage | 1.71 |
Financial Efficiency
Return on equity (ROE) is 5.38% and return on invested capital (ROIC) is 6.29%.
| Return on Equity (ROE) | 5.38% |
| Return on Assets (ROA) | 1.35% |
| Return on Invested Capital (ROIC) | 6.29% |
| Return on Capital Employed (ROCE) | 3.21% |
| Weighted Average Cost of Capital (WACC) | 8.65% |
| Revenue Per Employee | 180.88M |
| Profits Per Employee | 3.75M |
| Employee Count | 32 |
| Asset Turnover | 0.95 |
| Inventory Turnover | 4.59 |
Taxes
In the past 12 months, Kidswell Bio has paid 110.00 million in taxes.
| Income Tax | 110.00M |
| Effective Tax Rate | 47.83% |
Stock Price Statistics
The stock price has decreased by -42.62% in the last 52 weeks. The beta is 1.20, so Kidswell Bio's price volatility has been higher than the market average.
| Beta (5Y) | 1.20 |
| 52-Week Price Change | -42.62% |
| 50-Day Moving Average | 156.56 |
| 200-Day Moving Average | 190.54 |
| Relative Strength Index (RSI) | 40.59 |
| Average Volume (20 Days) | 435,055 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Kidswell Bio had revenue of JPY 5.79 billion and earned 120.00 million in profits. Earnings per share was 2.40.
| Revenue | 5.79B |
| Gross Profit | 1.48B |
| Operating Income | 132.00M |
| Pretax Income | 230.00M |
| Net Income | 120.00M |
| EBITDA | n/a |
| EBIT | 132.00M |
| Earnings Per Share (EPS) | 2.40 |
Full Income Statement Balance Sheet
The company has 3.44 billion in cash and 2.27 billion in debt, with a net cash position of 1.17 billion or 23.06 per share.
| Cash & Cash Equivalents | 3.44B |
| Total Debt | 2.27B |
| Net Cash | 1.17B |
| Net Cash Per Share | 23.06 |
| Equity (Book Value) | 2.28B |
| Book Value Per Share | 45.24 |
| Working Capital | 4.07B |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was 329.00 million and capital expenditures -17.00 million, giving a free cash flow of 312.00 million.
| Operating Cash Flow | 329.00M |
| Capital Expenditures | -17.00M |
| Depreciation & Amortization | n/a |
| Net Borrowing | 1.27B |
| Free Cash Flow | 312.00M |
| FCF Per Share | 6.17 |
Full Cash Flow Statement Margins
Gross margin is 25.48%, with operating and profit margins of 2.28% and 2.07%.
| Gross Margin | 25.48% |
| Operating Margin | 2.28% |
| Pretax Margin | 3.97% |
| Profit Margin | 2.07% |
| EBITDA Margin | n/a |
| EBIT Margin | 2.28% |
| FCF Margin | 5.39% |
Dividends & Yields
Kidswell Bio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -9.86% |
| Shareholder Yield | -9.86% |
| Earnings Yield | 1.70% |
| FCF Yield | 4.34% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on June 27, 2018. It was a forward split with a ratio of 2.
| Last Split Date | Jun 27, 2018 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Kidswell Bio has an Altman Z-Score of 3.09 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.09 |
| Piotroski F-Score | 5 |